Correlation Engine 2.0
Clear Search sequence regions


  • amoxicillin (2)
  • antibiotics (7)
  • beta lactam (9)
  • blood (2)
  • cefazolin (1)
  • cefoxitin (1)
  • human (4)
  • imipenem (1)
  • low (1)
  • meropenem (2)
  • piperacillin (2)
  • plasma (4)
  • time factors (1)
  • Sizes of these terms reflect their relevance to your search.

    Beta-lactam antibiotics are reported for some of them to be subject to a rapid degradation in infusion solutions and in human blood samples. However, the current data of stability available in blood samples are limited to a few number of beta-lactam antibiotics, and the methodology of the corresponding studies may be discussed. The objective of the present study is to evaluate the stability of 10 beta-lactam antibiotics in human plasma samples. Stability of amoxicillin, cefazolin, cefepime, cefotaxime, cefoxitin, ceftazidime, ceftriaxone, imipenem, meropenem, and piperacillin was evaluated at low and high concentrations at 20°C, 4°C, -20°C, and -80°C for 1, 7, 60, and 90 days, respectively. Amoxicillin, cefepime, meropenem, and piperacillin were the least stable antibiotics. The maximum durations allowing the stability for all the evaluated beta-lactams at both tested concentrations were estimated at 3 h, 23 h, 10 days, and 35 days at 20°C, 4°C, -20°C, and -80°C, respectively. We recommend to transport antibiotic plasma samples in ice at 4°C and even at -20°C if these samples come from external hospitals. Ideally, plasma samples should be stored at -80°C if possible; if not, the analysis of the samples should be performed as soon as possible in the limit of 10 days after a storage at -20°C. © 2023 Société Française de Pharmacologie et de Thérapeutique. Published by John Wiley & Sons Ltd.

    Citation

    Matthieu Brenkman, Tom Cartau, Elise Pape, Allan Kolodziej, Alexandre Charmillon, Emmanuel Novy, Jean-Yves Jouzeau, Nicolas Gambier, Julien Scala-Bertola. In vitro stability study of 10 beta-lactam antibiotics in human plasma samples. Fundamental & clinical pharmacology. 2024 Jun;38(3):502-510

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 37985813

    View Full Text